Loxo Oncology
Stamford, US · Founded 2013 · 2 known investors
Founders & leadership
AN
Avi NaiderNamed on SEC filing
JB
James BarrettNamed on SEC filing
KF
Keith FlahertyNamed on SEC filing
DB
David BonitaNamed on SEC filing
JH
Joshua H. BilenkerNamed on SEC filing
Board
DG
Dov GoldsteinBoard director
SE
Steven ElmsBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$23.9M disclosed across 1 round · 2014
▶$23.9MraisedMay 2014 · 7 investors · BiotechnologyRule 506(b)
▶$23.9MraisedMay 2014 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Avi NaiderDirector
- Dov GoldsteinDirector
- James BarrettDirector
- Keith FlahertyDirector
- David BonitaDirector
- Joshua H. BilenkerExecutive Officer, Director
- Steven ElmsDirector
- Offering amount
- $23.9M
- Amount sold
- $23.9M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Loxo Oncology's investors?
- Loxo Oncology's investors include Aisling Capital, New Enterprise Associates (NEA).
- How much funding has Loxo Oncology raised?
- Loxo Oncology has disclosed $23.9M raised across 1 round.
- Where is Loxo Oncology headquartered?
- Loxo Oncology is headquartered in Stamford, US.